Advanced search
Publication Cover
Modern Rheumatology Volume 25, 2015 - Issue 2
Journal homepage
2,621
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks

Hiroto TsuboiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Isao MatsumotoDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Shinya HagiwaraDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Tomoya HirotaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Hiroyuki TakahashiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Hiroshi EbeDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Masahiro YokosawaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Chihiro HagiyaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Hiromitsu AsashimaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Chinatsu TakaiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Haruka MikiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Naoto UmedaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Yuya KondoDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Hiroshi OgishimaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Takeshi SuzukiDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan
,
Shintaro HirataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Fukuoka Prefecture, Japan
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Fukuoka Prefecture, Japan
,
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu City, Fukuoka Prefecture, Japan
,
Yoshiro HoraiUnit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
,
Hideki NakamuraUnit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
,
Atsushi KawakamiUnit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
&
Takayuki SumidaDepartment of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, JapanCorrespondence[email protected]
 show all
Pages 187-193 | Received 10 Jul 2014, Accepted 30 Jul 2014, Published online: 11 Sep 2014

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Soledad Retamozo, Antoni Sisó-Almirall, Alejandra Flores-Chávez, Manuel Ramos-Casals & Pilar Brito-Zerón. (2021) An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opinion on Pharmacotherapy 22:17, pages 2359-2371.
Read now
Toshio Odani & John A. Chiorini. (2019) Targeting primary Sjögren’s syndrome. Modern Rheumatology 29:1, pages 70-86.
Read now
Takayuki Sumida, Naoto Azuma, Masafumi Moriyama, Hiroyuki Takahashi, Hiromitsu Asashima, Fumika Honda, Saori Abe, Yuko Ono, Tomoya Hirota, Shintaro Hirata, Yoshiya Tanaka, Toshimasa Shimizu, Hideki Nakamura, Atsushi Kawakami, Hajime Sano, Yoko Ogawa, Kazuo Tsubota, Koufuchi Ryo, Ichiro Saito, Akihiko Tanaka, Seiji Nakamura, Etsuko Takamura, Masao Tanaka, Katsuya Suzuki, Tsutomu Takeuchi, Noriyuki Yamakawa, Tsuneyo Mimori, Akiko Ohta, Susumu Nishiyama, Toshio Yoshihara, Yasunori Suzuki, Mitsuhiro Kawano, Minako Tomiita & Hiroto Tsuboi. (2018) Clinical practice guideline for Sjögren’s syndrome 2017. Modern Rheumatology 28:3, pages 383-408.
Read now
Hiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, Tomoya Hirota, Hiroyuki Takahashi, Hiroshi Ebe, Masahiro Yokosawa, Mizuki Yagishita, Hidenori Takahashi, Izumi Kurata, Ayako Ohyama, Fumika Honda, Hiromitsu Asashima, Haruka Miki, Naoto Umeda, Yuya Kondo, Shintaro Hirata, Kazuyoshi Saito, Yoshiya Tanaka, Yoshiro Horai, Hideki Nakamura, Atsushi Kawakami & Takayuki Sumida. (2016) Effectiveness of abatacept for patients with Sjögren’s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren’s syndrome Endocrinopathy) trial. Modern Rheumatology 26:6, pages 891-899.
Read now
Shinya Hagiwara, Hiroto Tsuboi, Fumika Honda, Hidenori Takahashi, Izumi Kurata, Ayako Ohyama, Mizuki Yagishita, Saori Abe, Yuko Kurashima, Syunta Kaneko, Hoshimi Kawaguchi, Hiroyuki Takahashi, Hiroshi Ebe, Masahiro Yokosawa, Hiromitsu Asashima, Tomoya Hirota, Naoto Umeda, Yuya Kondo, Isao Matsumoto & Takayuki Sumida. (2016) Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis. Modern Rheumatology 26:6, pages 857-862.
Read now

Articles from other publishers (23)

Hiroto Tsuboi, Hirofumi Toko, Fumika Honda, Saori Abe, Hiroyuki Takahashi, Mizuki Yagishita, Shinya Hagiwara, Ayako Ohyama, Yuya Kondo, Kazuhisa Nakano, Yoshiya Tanaka, Toshimasa Shimizu, Hideki Nakamura, Atsushi Kawakami, Yuichiro Fujieda, Tatsuya Atsumi, Yasunori Suzuki, Mitsuhiro Kawano, Naoshi Nishina, Yuko Kaneko, Tsutomu Takeuchi, Hitomi Kobayashi, Masami Takei, Michihiro Ogasawara, Naoto Tamura, Yoshinari Takasaki, Kazuhiro Yokota, Yuji Akiyama, Toshihide Mimura, Kosaku Murakami, Tsuneyo Mimori, Shiro Ohshima, Naoto Azuma, Hajime Sano, Susumu Nishiyama, Isao Matsumoto & Takayuki Sumida. (2023) Abatacept ameliorates both glandular and extraglandular involvements in patients with Sjögren’s syndrome associated with rheumatoid arthritis: Findings from an open-label, multicentre, 1-year, prospective study: The ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren’s Syndrome Endocrinopathy) and ROSE II trials. Modern Rheumatology 33:1, pages 160-168.
Crossref
Zhen Tan, Li Wang & Xiaomei Li. (2022) Composition and regulation of the immune microenvironment of salivary gland in Sjögren’s syndrome. Frontiers in Immunology 13.
Crossref
Rosanna Dammacco, Silvana Guerriero, Giovanni Alessio & Franco Dammacco. (2021) Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review. International Ophthalmology 42:2, pages 689-711.
Crossref
Alessia Alunno, Roberto Gerli & Elena Bartoloni. (2021) Comment on: Equal rights in autoimmunity: is Sjögren's syndrome ever ‘secondary’?. Rheumatology 60:1, pages e32-e33.
Crossref
Yang Huang, Guangxia Yang, Jing Fei, Yingyi Wu & Juzhen Yan. (2020) Bufotalin ameliorates experimental Sjögren’s syndrome development by inhibiting Th17 generation. Naunyn-Schmiedeberg's Archives of Pharmacology 393:10, pages 1977-1985.
Crossref
Florian Kollert & Benjamin A Fisher. (2020) Equal rights in autoimmunity: is Sjögren’s syndrome ever ‘secondary’?. Rheumatology 59:6, pages 1218-1225.
Crossref
Clio P. Mavragani & Haralampos M. Moutsopoulos. (2020) Sjögren's syndrome: Old and new therapeutic targets. Journal of Autoimmunity 110, pages 102364.
Crossref
Jolien F van Nimwegen, Esther Mossel, Greetje S van Zuiden, Robin F Wijnsma, Konstantina Delli, Alja J Stel, Bert van der Vegt, Erlin A Haacke, Lisette Olie, Leonoor I Los, Gwenny M Verstappen, Sarah A Pringle, Fred K L Spijkervet, Frans G M Kroese, Arjan Vissink, Suzanne Arends & Hendrika Bootsma. (2020) Abatacept treatment for patients with early active primary Sjögren's syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study). The Lancet Rheumatology 2:3, pages e153-e163.
Crossref
Clara M Castillejo Becerra, Yue Ding, Beatrice Kenol, Andrew Hendershot & Alexa Simon Meara. (2020) Ocular side effects of antirheumatic medications: a qualitative review. BMJ Open Ophthalmology 5:1, pages e000331.
Crossref
Rana Mongroo, Bivin Varghese & Steven Carsons. 2020. Sjogren's Syndrome. Sjogren's Syndrome 211 234 .
Charalampos Skarlis, Nikolaos Marketos & Clio P. Mavragani. (2019) Biologics in Sjögren's syndrome. Pharmacological Research 147, pages 104389.
Crossref
Renaud Felten, Florence Scher, Jean Sibilia, Jacques-Eric Gottenberg & Laurent Arnaud. (2019) The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials. Autoimmunity Reviews 18:6, pages 576-582.
Crossref
Leena Äyräväinen, Anna Maria Heikkinen, Antti Kuuliala, Kirsi Ahola, Riitta Koivuniemi, Jaakko Peltola, Anni Suomalainen, Eeva Moilanen, Mari Hämäläinen, Leena Laasonen, Jukka H. Meurman & Marjatta Leirisalo-Repo. (2018) Activity of rheumatoid arthritis correlates with oral inflammatory burden. Rheumatology International 38:9, pages 1661-1669.
Crossref
Xiaoyun Chen, Huaxun Wu & Wei Wei. (2018) Advances in the diagnosis and treatment of Sjogren’s syndrome. Clinical Rheumatology 37:7, pages 1743-1749.
Crossref
John A. Gonzales & Thomas M. Lietman. (2018) Ocular Involvement in Sjögren’s Syndrome: Advances in Therapy. Current Treatment Options in Rheumatology 4:1, pages 99-109.
Crossref
Chiu Sum Chu & Chi Chiu Mok. (2017) Diagnosis and treatment of primary Sjogren’s syndrome: an update. Hong Kong Bulletin on Rheumatic Diseases 17:1, pages 6-11.
Crossref
Clio P. Mavragani. (2017) Mechanisms and New Strategies for Primary Sjögren's Syndrome. Annual Review of Medicine 68:1, pages 331-343.
Crossref
M Tahara, H Tsuboi, S Segawa, H Asashima, M Iizuka-Koga, T Hirota, H Takahashi, Y Kondo, M Matsui, I Matsumoto & T Sumida. (2017) RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis. Clinical and Experimental Immunology 187:2, pages 213-224.
Crossref
Peter C. Taylor. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology 1020 1043.e4 .
Pilar Brito-Zerón, Soledad Retamozo, Hoda Gheitasi & Manuel Ramos-Casals. (2016) Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects. Drugs 76:17, pages 1601-1623.
Crossref
Dieter Schöffel. (2016) Das Sjögren-Syndrom lässt exokrine Drüsen versiegen. Orthopädie & Rheuma 19:4, pages 17-23.
Crossref
V.C. Kyttaris & G.C. Tsokos. 2016. Sjogren's Syndrome. Sjogren's Syndrome 291 297 .
C.P. Mavragani & M.N. Manoussakis. 2016. Sjogren's Syndrome. Sjogren's Syndrome 35 45 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.